Suchergebnisse - "He, Jianxing"

PubPharm (802)

101

Anlotinib as third- or further-line therapy for short-term relapsed small-cell lung cancer : subgroup analysis of a randomized phase 2 study (ALTER1202)

enthalten in: Frontiers of medicine | 2022

von Shi, J. | Cheng, Y. | Wang, Q. | +8

102

Video-assisted Thoracic Surgery for Main Bronchial Rupture After Blunt Chest Trauma in Children

enthalten in: The Annals of thoracic surgery | 2022

von Guo, Z. | He, J. | Yang, C. | +4

103

Outcomes after lung transplantation among Chinese patients with connective tissue disease-associated interstitial lung disease and pulmonary hypertension : a retrospective cohort study

enthalten in: Clinical and experimental rheumatology | 2022

von Ju, C. | Lian, Q. | Chen, A. | +6

104

International expert consensus on immunotherapy for early-stage non-small cell lung cancer

enthalten in: Translational lung cancer research | 2022

von Liang, W. | Cai, K. | Cao, Q. | +81

105

Predicting EGFR mutation status in lung adenocarcinoma presenting as ground-glass opacity : utilizing radiomics model in clinical translation

enthalten in: European radiology | 2022

von Cheng, B. | Deng, H. | Zhao, Y. | +15

106

Antifungal prophylactic effectiveness and intrapulmonary concentrations of voriconazole versus posaconazole in lung transplant recipients

enthalten in: Medical mycology | 2022

von Ju, C. | Lian, Q. | Chen, A. | +7

107

The efficacy and safety of IBI314 on delta and omicron variant of SARS-CoV-2 : First-in-human evidence

enthalten in: The Journal of infection | 2022

von Sang, L. | Cheng, B. | Yu, Y. | +12

108

Gout and susceptibility and severity of COVID-19 : A bidirectional Mendelian randomization analysis

enthalten in: The Journal of infection | 2022

von Peng, H. | Wu, X. | Xiong, S. | +4

CommentIn: J Infect. 2023 Jun;86(6):620-621. - PMID 36822412

109

USE OF ICOTINIB IN POSTOPERATIVE ADJUVANT THERAPY FOR NON-SMALL CELL LUNG CANCER

enthalten in: Europäisches Patentamt | 2022

von ZHOU CAICUN | TAN FENLAI | HE JIANXING | +14

110

Dynamic monitoring serum tumor markers to predict molecular features of EGFR-mutated lung cancer during targeted therapy

enthalten in: Cancer medicine | 2022

von Chen, Z. | Liu, L. | Zhu, F. | +15